Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Indonesian Version of Oxford Cognitive Screen-Plus Test in Stroke Patient

NCT: NCT07817784 · NOT_YET_RECRUITING

NCT IDNCT07817784
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2026-12-31
SponsorUniversitas Padjadjaran (OTHER)
First posted
Last updated

Brief Summary

The incidence of stroke increases every year throughout the world. Neuropsychological assessment is the best way to identify post-stroke cognitive dysfunction. The importance of cognitive function in the post stroke rehabilitation program process requires a tool that can detect cognitive disorders more specifically and more sensitively. The investigator aim in this study was to develop Indonesian version of the OCS - Plus among stroke patient in Indonesia.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑